Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 21

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 7, 2014; 20(21): 6400-6411
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6400

Full Size Figure Download Figure

Figure 2 Metabolism of omeprazole, lansoprazole, rabeprazole, and esomeprazole by cytochrome P450 isoenzymes. Reproduced from Chang et al[61].

Citation: Sugimoto M, Furuta T. Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. World J Gastroenterol 2014; 20(21): 6400-6411
URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6400.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6400

Sugimoto M, Furuta T. Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. World J Gastroenterol 2014; 20(21): 6400-6411 [PMID: 24914361 DOI: 10.3748/wjg.v20.i21.6400]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.